<!DOCTYPE html>
<html>
<title>W3.CSS</title>
<meta name="viewport" content="width=device-width, initial-scale=1">
<link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
<body>

<div class="w3-container">
  <center><h1><b><u>Sports And Banned Substances</u> <img src="https://www.friskfriidrott.se/wp-content/uploads/2017/11/drugs_prohibited_1600_clr_12088.jpg" height="60" width="60"></b></h1></center>
  <br>

  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th>Sport</th>
        <th>Banned Substances</th>
       
      </tr>
    </thead>
    <tr>
      <td>Archery</td>
      <td>Anabolic steroids , Hormones including erythropoietin (EPO) , human growth hormone (hGH) ,
         insulin-like growth factor (IGF-1) , human chorionic gonadotrophin (hCG) , adrenocorticotrpic hormone (ACTH)</td>
    
    </tr>
    <tr>
      <td>Cricket
      </td>
      <td>Cannabis and steroids</td>
     
    </tr>
    <tr>
      <td>Golf </td>
      <td>Beta blockers</td>

    </tr>
    <tr>
      <td>Mini Golf </td>
      <td>Beta blockers</td>

    </tr>
    <tr>
      <td>Shooting</td>
      <td>Beta blockers</td>

    </tr>
    <tr>
      <td>Snow Boarding</td>
      <td>Beta blockers</td>

    </tr>
    <tr>
      <td>Spearfishing</td>
      <td>Beta blockers</td>

    </tr>
    <tr>
      <td>Target Shooting</td>
      <td>Beta blockers</td>

    </tr>
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th>Non Approved Substances</th>
       
      </tr>
    <tr>
      <td>Any pharmacological substance which is not addressed by any of the subsequent
        sections of the List and with no current approval by any governmental regulatory health
        authority for human therapeutic use (e.g. drugs under pre-clinical or clinical development
        or discontinued, designer drugs, substances approved only for veterinary use) is
        prohibited at all times.
        This class covers many different substances including but not limited to BPC-157, 2,4-
        Dinitrophenol (DNP) and Troponin Activators (e.g. Reldesemtiv and Tirasemtiv).</td>
     
     
    </tr>
    
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th>Anabolic agents</th>
       
      </tr>
    <tr>
      <td>• 1-Androstenediol (5ɑ-androst-1-ene-3ß,
        17ß-diol)<br>
        • 1-Androstenedione (5ɑ-androst-1-ene-3,
        17-dione)<br>
        • 1-Androsterone (3ɑ-hydroxy-5a-androst-1-
        ene-17-one)<br>
        • 1-Epiandrosterone (3ß-hydroxy-5ɑ-androst1-ene-17-one)<br>
        • 1-Testosterone (17ß-hydroxy-5ɑ-androst-1-
        en-3-one)<br>
        • 4-Androstenediol (androst-4-ene-3ß,
        17ß-diol)<br>
        • 4-Hydroxytestosterone
        (4,17ß-dihydroxyandrost-4-en-3-one)<br>
        • 5-Androstenedione (androst-5-ene-3,17-dione)<br>
        • 7ɑ-Hydroxy-DHEA<br>
        • 7ß-Hydroxy-DHEA<br>
        • 7-Keto-DHEA<br>
        • 11ß-Methyl-19-nortestosterone<br>
        • 17ɑ-Methylepithiostanol (epistane)<br>
        • 19-Norandrostenediol (estr-4-ene-3,17-diol)<br>
        • 19-Norandrostenedione (estr-4-ene-3,17-dione)<br>
        • Androst-4-ene-3,11,17- trione
        (11-ketoandrostenedione, adrenosterone)<br>
        • Androstanolone (5ɑ-dihydrotestosterone,
        17ß-hydroxy-5ɑ-androstan-3-one)<br>
        • Androstenediol (androst-5-ene-3ß,17ß-diol)<br>
        • Androstenedione<br>
        • Bolasterone<br>
        • Boldenone<br>
        • Boldione (androsta-1,4-diene-3,17-dione)<br>
        • Calusterone<br>
        • Clostebol<br>
        • Danazol ([1,2]oxazolo[4’,5’:2,3]pregna-4-en20-yn-17ɑ-ol)<br>
        • Dehydrochlormethyltestosterone (4-chloro17ß-hydroxy-17ɑ-methylandrosta-1,4-dien-3-
        one)<br>
        • Desoxymethyltestosterone (17ɑ-methyl5ɑ-androst-2-en-17ß-ol and 17ɑ-methyl-5ɑandrost-3-en-17ß-ol)<br>
        • Dimethandrolone (7ɑ,11ß-Dimethyl-19-
        nortestosterone)<br>
        • Drostanolone<br>
        • Epiandrosterone (3ß-hydroxy-5ɑ-androstan17-one)<br>
        • Epi-dihydrotestosterone (17ß-hydroxy-5ßandrostan-3-one)<br>
        • Epitestosterone<br>
        • Ethylestrenol (19-norpregna-4-en-17ɑ-ol)<br>
        • Fluoxymesterone<br>
        •  Formebolone<br>
        • Furazabol (17ɑ-methyl [1,2,5]
        oxadiazolo[3’,4’:2,3]-5ɑ-androstan-17ß-ol)<br>
      </td>
     
     </tr>
    </table>
    <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th>Peptide hormones, growth factors, related substances and mimetics</th>
       
      </tr>
    <tr>
      <td>• ERYTHROPOIETINS (EPO) AND AGENTS AFFECTING ERYTHROPOIESIS<br>
        1 Erythropoietin receptor agonists, e.g. darbepoetins (dEPO); erythropoietins (EPO);
        EPO-based constructs [e.g. EPO-Fc, methoxy polyethylene glycol-epoetin beta
        (CERA)]; EPO-mimetic agents and their constructs (e.g. CNTO-530, peginesatide).<br>
        2 Hypoxia-inducible factor (HIF) activating agents, e.g. cobalt; daprodustat (GSK1278863);
        IOX2; molidustat (BAY 85-3934); roxadustat (FG-4592); vadadustat (AKB-6548); xenon.<br>
        3 GATA inhibitors, e.g. K-11706.<br>
        4 Transforming growth factor beta (TGF-ß) signalling inhibitors, e.g. luspatercept;
        sotatercept.<br>
        5 Innate repair receptor agonists, e.g. asialo EPO; carbamylated EPO (CEPO).<br>
        • PEPTIDE HORMONES AND THEIR RELEASING FACTORS<br>
        1 Testosterone-stimulating peptides in males including, but not limited to:
        chorionic gonadotrophin (CG),luteinizing hormone (LH), gonadotrophin- releasing hormone (GnRH, gonadorelin) and its agonist analogues
        (e.g. buserelin, deslorelin, goserelin, histrelin, leuprorelin, nafarelin and triptorelin), kisspeptin and its agonist analogues<br>
        2 Corticotrophins and their releasing factors, e.g. corticorelin and tetracosactide<br>
        3 Growth hormone (GH), its analogues and fragments including, but not limited to:
        growth hormone analogues, e.g. lonapegsomatropin, somapacitan and somatrogon
        growth hormone fragments, e.g. AOD-9604 and hGH 176-191<br>
        4 Growth hormone releasing factors, including, but not limited to:
        growth hormone-releasing hormone (GHRH) and its analogues (e.g. CJC-1293,
        CJC-1295, sermorelin and tesamorelin)
        growth hormone secretagogues (GHS) and their mimetics [e.g. anamorelin,
        capromorelin, ibutamoren (MK-677), ipamorelin, lenomorelin (ghrelin), macimorelin and
        tabimorelin],
        GH-releasing peptides (GHRPs) [e.g. alexamorelin, examorelin (hexarelin), GHRP-1,
        GHRP-2 (pralmorelin), GHRP-3, GHRP-4, GHRP-5 and GHRP-6]<br>
      </td>
     
    </tr>
    
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th>Beta-2 agonists</th>
       
      </tr>
    <tr>
      <td>• Arformoterol<br>
        • Fenoterol<br>
        • Formoterol<br>
        • Higenamine<br>
        • Indacaterol<br>
        • Levosalbutamol<br>
        • Olodaterol<br>
        • Procaterol<br>
        • Reproterol<br>
        • Salbutamol<br>
        • Salmeterol<br>
        • Terbutaline<br>
        • Tretoquinol
        (trimetoquinol)<br>
        • Tulobuterol<br>
        • Vilanterol<br>
      </td>
     
     
    </tr>
    
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th> Hormone and metabolic modulators</th>
       
      </tr>
    <tr>
      <td>• 2-Androstenol (5ɑ-androst-2-en-17-ol)<br>
        • 2-Androstenone (5ɑ-androst-2-en-17-one)<br>
        • 3-Androstenol (5ɑ-androst-3-en-17-ol)<br>
        • 3-Androstenone (5ɑ-androst-3-en-17-one)<br>
        • 4-Androstene-3,6,17 trione (6-oxo)<br>
        • Aminoglutethimide<br>
        • Anastrozole<br>
        • Androsta-1,4,6-triene-3,17-dione
        (androstatrienedione)<br>
        • Androsta-3,5-diene-7,17-dione (arimistane)<br>
        • Exemestane<br>
        • Formestane<br>
        • Letrozole<br>
        • Testolactone<br>
        • Bazedoxifene<br>
        • Clomifene<br>
        • Cyclofenil<br>
        • Fulvestrant<br>
        • Ospemifene<br>
        • Raloxifene<br>
        • Tamoxifen<br>
        • Toremifene<br>
      </td>
     
     
    </tr>
    
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th>Diuretics and masking agents</th>
       
      </tr>
    <tr>
      <td>• Diuretics such as:
        Acetazolamide; amiloride; bumetanide; canrenone; chlortalidone; etacrynic acid; furosemide;
        indapamide; metolazone; spironolactone; thiazides, e.g. bendroflumethiazide, chlorothiazide
        and hydrochlorothiazide; torasemide; triamterene;<br>
        • Vaptans, e.g. conivaptan, mozavaptan, tolvaptan;<br>
        • Plasma expanders by intravenous administration such as:
        Albumin, dextran, hydroxyethyl starch, mannitol;<br>
        • Desmopressin;<br>
        • Probenecid;<br>
        and other substances with a similar chemical structure or similar biological effect(s).<br>
        
      </td>
     </tr>  
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th>Stimulants (in-competition)</th>
       
      </tr>
    <tr>
      <td>• Adrafinil<br>
        • Amfepramone<br>
        • Amfetamine<br>
        • Amfetaminil<br>
        • Amiphenazole<br>
        • Benfluorex<br>
        • Benzylpiperazine<br>
        • Bromantan<br>
        • Clobenzorex<br>
        • Cocaine<br>
        • Cropropamide<br>
        • Crotetamide<br>
        • Fencamine<br>
        • Fenetylline<br>
        • Fenfluramine<br>
        • Fenproporex<br>
        • Fonturacetam
        [4-phenylpiracetam (carphedon)]<br>
        • Furfenorex<br>
        • Lisdexamfetamine<br>
        • Mefenorex<br>
        • Mephentermine<br>
        • Mesocarb<br>
        • Metamfetamine(d-)<br>
        • p-methylamfetamine<br>
        • Modafinil<br>
        • Norfenfluramine<br>
        • Phendimetrazine<br>
        • Phentermine<br>
        • Prenylamine<br>
        • Prolintane<br>
        
      </td>
     </tr>  
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th>Narcotics (in-competition)</th>
       
      </tr>
    <tr>
      <td>• Buprenorphine<br>
        • Dextromoramide<br>
        • Diamorphine
        (heroin)<br>
        • Fentanyl and its
        derivatives<br>
        • Hydromorphone<br>
        • Methadone<br>
        • Morphine<br>
        • Nicomorphine<br>
        • Oxycodone<br>
        • Oxymorphone<br>
        • Pentazocine<br>
        • Pethidine<br>
        • Tramadol<br>
        
      </td>
     </tr>  
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th> Cannabinoids (in-competition)</th>
       
      </tr>
    <tr>
      <td>• In cannabis (hashish, marijuana) and cannabis products<br>
        • Natural and synthetic tetrahydrocannabinols (THCs)<br>
        • Synthetic cannabinoids that mimic the effects of THC<br>
        
      </td>
     </tr>  
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th> Glucocorticoids (in-competition)</th>
       
      </tr>
    <tr>
      <td>• Beclometasone<br>
        • Betamethasone<br>
        • Budesonide<br>
        • Ciclesonide<br>
        • Cortisone<br>
        • Deflazacort<br>
        • Dexamethasone<br>
        • Flunisolide<br>
        • Fluocortolone<br>
        • Fluticasone<br>
        • Hydrocortisone<br>
        • Methylprednisolone<br>
        • Mometasone<br>
        • Prednisolone<br>
        • Prednisone<br>
        • Triamcinolone acetonide <br>
        
      </td>
     </tr>  
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th> Manipulation of blood and blood components</th>
       
      </tr>
    <tr>
      <td>1. The Administration or reintroduction of any quantity of autologous, allogenic
        (homologous) or heterologous blood, or red blood cell products of any origin into the
        circulatory system except donation by Athletes of plasma or plasma components by
        plasmapheresis performed in a registered collection center.<br>
        2. Artificially enhancing the uptake, transport or delivery of oxygen.
        Including, but not limited to:
        Perfluorochemicals; efaproxiral (RSR13); voxelotor and modified haemoglobin
        products, e.g. haemoglobin-based blood substitutes and microencapsulated
        haemoglobin products, excluding supplemental oxygen by inhalation.<br>
        3. Any form of intravascular manipulation of the blood or blood components by
        physical or chemical means.<br>
        
        
      </td>
     </tr>  
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th>Chemical and physical manipulation</th>
       
      </tr>
    <tr>
      <td>1. Tampering, or Attempting to Tamper, to alter the integrity and validity of Samples
        collected during Doping Control.
        Including, but not limited to:
        Sample substitution and/or adulteration, e.g. addition of proteases to Sample.<br>
        2. Intravenous infusions and/or injections of more than a total of 100 mL per 12-hour
        period except for those legitimately received in the course of hospital treatments,
        surgical procedures or clinical diagnostic investigations.<br>
        
      </td>
     </tr>  
  </table>
  <br><br>
  <table class="w3-table-all w3-hoverable">
    <thead>
      <tr class="w3-light-green">
        <th> Gene doping</th>
       
      </tr>
    <tr>
      <td>The following, with the potential to enhance sport performance, are prohibited:<br>
        1. The use of nucleic acids or nucleic acid analogues that may alter genome
        sequences and/or alter gene expression by any mechanism. This includes but is not
        limited to gene editing, gene silencing and gene transfer technologies.<br>
        2. The use of normal or genetically modified cells.<br>
        
      </td>
     </tr>  
  </table>
</div>
<center><a href="MHome.html">back</a></center>
</body>
</html> 
